Morgan Stanley Downgrades Stride to Equal-Weight, Announces $46 Price Target

Morgan Stanley analyst Greg Parrish downgrades Stride (NYSE:LRN) from Overweight to Equal-Weight and announces $46 price target.

Morgan Stanley analyst Greg Parrish downgrades Stride (NYSE:LRN) from Overweight to Equal-Weight and announces $46 price target.

Total
0
Shares
Related Posts